Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency

W. Ruitenbeek, P. J E Poels, D. M. Turnbull, B. Garavaglia, R. A. Chalmers, R. W. Taylor, F. J M Gabreels

Research output: Contribution to journalArticlepeer-review


A previously asymptomatic 30 year old man presented with rhabdomyolysis, muscle weakness, and acute encephalopathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. Urinary excretion of carnitine and glycine esters and biochemical examination of skeletal muscle and fibroblasts led to the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency. A point mutation at nucleotide position 985 of the coding region of the MCAD gene was found. The ;MCAD protein was synthesised in the patient's fibroblasts at a normal rate, but was unstable. In general, patients in whom the 985 point mutation has been established show much more severe clinical symptoms and other symptoms than those seen in this patient. The relation of the 985 point mutation and the residual MCAD activity to the symptoms is not as straightforward as previously thought.

Original languageEnglish
Pages (from-to)209-214
Number of pages6
JournalJournal of Neurology, Neurosurgery and Psychiatry
Issue number2
Publication statusPublished - 1995


  • Encephalopathy
  • Medium chain acyl-CoA dehydrogenase deficiency
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology


Dive into the research topics of 'Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency'. Together they form a unique fingerprint.

Cite this